Denmark· DK-28105402814
Harvoni
A sofosbuvir and ledipasvir product containing ledipasvir, sofosbuvir, registered in Denmark by Gilead Sciences Ireland UC. The same ATC class is registered in 13 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Sofosbuvir and ledipasvir is registered in 13 of 19 countries.
Countries holding a registration under ATC J05AP51 (sofosbuvir and ledipasvir), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 8 of them publish a price we can compare per daily dose
Sofosbuvir and ledipasvir · ATC J05AP51
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- United Kingdom
- United Statesprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Ledipasvir, Sofosbuvir
- Manufacturer
- Gilead Sciences Ireland UC
- Country
- Denmark (DK)
- ATC code
- J05AP51
- ATC class
- Sofosbuvir and ledipasvir
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28105402814
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J05AP51
Sofosbuvir and ledipasvir, as other registers publish it.
- PolandHarvoniGilead Sciences Ireland UC
- PolandHarvoniGilead Sciences Ireland UC
- DenmarkHarvoniGilead Sciences Ireland UC
- FinlandHarvoniGilead Sciences Ireland UC
- FinlandHarvoniGilead Sciences Ireland UC
- FinlandHarvoniGilead Sciences Ireland UC
- FinlandHarvoniGilead Sciences Ireland UC
- PolandHarvoniGilead Sciences Ireland UC
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/db2a961a-91a6-4fc4-b8d4-7b0ce8db9e8b GET /v1/drugs/db2a961a-91a6-4fc4-b8d4-7b0ce8db9e8b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "filmovertrukne tabletter",
"source": "dkma",
"strength": "400 mg +90 mg",
"auth_role": "MOD",
"dk_drugid": "28105402814",
"substance": "Ledipasvir, Sofosbuvir",
"auth_procedure": "Central",
"in_medicinpriser": true,
"registration_date_serial": "41960"
}See everything about sofosbuvir and ledipasvir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.